Novartis just released this. I haven’t read it carefully yet but it does say they submitted Fingolimod’s FDA and EMEA applications in December.
Novartis International AG (CH) - Novartis oral MS therapy FTY720 shows reduced risk of confirmed disability progression as published in New England Journal of Medicine
http://hugin.info/134323/R/1375459/337469.pdf
Fingolimod pill (FTY 720) filed for FDA approval
-
- Family Elder
- Posts: 366
- Joined: Mon Dec 21, 2009 3:00 pm
- Location: Houston, TX
- Contact:
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 9744 Views
-
Last post by NHE